We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01735643
Previous Study | Return to List | Next Study

Lifestyle Intervention With an Interactive Video Game for Type 2 Diabetes Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01735643
First Posted: November 28, 2012
Last Update Posted: November 28, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Novartis Pharmaceuticals
Nintendo of Europe GmbH
Information provided by (Responsible Party):
Stephan Martin, West German Center of Diabetes and Health
  Purpose
Due to overweight and unhealthy lifestyle the number of patients with type 2 diabetes mellitus is increasing. Although in early phases the disease might be successfully treated by lifestyle change patients lack for motivation. Instead of increasing anti-diabetic medication a highly motivational system with low inhibition threshold is needed. Therefore, the investigators analyzed if regular use of the interactive videogame Wii Fit Plus over 12 weeks is able to improve HbA1c and weight in patients with type 2 diabetes.

Condition Intervention Phase
Type 2 Diabetes Mellitus Device: interactive videogame Wii Fit Plus Other: waiting Early Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Spielend zu Mehr Bewegung - Lebensstilintervention Durch Das Interaktive Video-spiel "Wii Fit Plus" Bei Personen Mit Typ-2-Diabetes Mellitus

Resource links provided by NLM:


Further study details as provided by Stephan Martin, West German Center of Diabetes and Health:

Primary Outcome Measures:
  • HbA1c [ Time Frame: 12 weeks ]

Secondary Outcome Measures:
  • weight [ Time Frame: 12 weeks ]

Enrollment: 220
Study Start Date: January 2011
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: interactive videogame intervention Device: interactive videogame Wii Fit Plus
Use of the interactive videogame Wii Fit Plus für 12 weeks.
Other Name: Wii Fit Plus
Experimental: waiting group Other: waiting
waiting for 12 weeks

Detailed Description:
Patients with type 2 diabetes were recruited via treating physicians or articles in magazines and newspapers. Participants were randomized in an intervention and a control group. The intervention group was sent the Wii, the balance board and the interactive video game Wii Fit Plus and were instructed to use these items 30 minutes each day during the next 12 weeks. The control group got the items 12 weeks later. At begin and after 12 weeks of intervention participants (and additionally for the control group: after 12 weeks of waiting phase) sent their health parameters, which had been measured in the context of the disease management program type 2 diabetes as well as questionnaires about physical activity and quality of life to the study center.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • type 2 diabetes mellitus
  • diabetes duration < 5 years
  • age 50-75 years
  • body mass index > or equal to 27 kg/m2
  • participating in the disease management programme type 2 diabetes mellitus
  • physical and mental able for study participation

Exclusion Criteria:

  • insulin or antidiabetic medication (exception: Metformin and DPP-IV-Inhibitors)
  • regular physical activity
  • depression
  • tumors
  • change of smoking status during the past 6 months or during the study
  • participation in other studies during the past 6 months
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01735643


Locations
Germany
West German Center of Diabetes and Health
Düsseldorf, Germany, 40591
Sponsors and Collaborators
West German Center of Diabetes and Health
Novartis Pharmaceuticals
Nintendo of Europe GmbH
Investigators
Principal Investigator: Stephan Martin, MD West German Center of Diabetes and Health
  More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Stephan Martin, MD, West German Center of Diabetes and Health
ClinicalTrials.gov Identifier: NCT01735643     History of Changes
Other Study ID Numbers: Wii study
First Submitted: November 22, 2012
First Posted: November 28, 2012
Last Update Posted: November 28, 2012
Last Verified: November 2012

Keywords provided by Stephan Martin, West German Center of Diabetes and Health:
type 2 diabetes mellitus
physical activity
lifestyle change
motivation
patient empowerment

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases